Nocturia in Patients With Parkinson's Disease

Overview

Journal Mov Disord Clin Pract

Publisher Wiley

Specialty Neurology

Date 2018 Oct 27

PMID 30363570

Citations 7

Authors

Matthew Smith

Jai Seth

Amit Batla

Johann Hofereiter

Kailash P Bhatia

Jalesh N Panicker

Affiliations

Soon will be listed here.

Abstract

Background: Waking up from sleep more than once to pass urine, known as nocturia, is an important nonmotor symptom in Parkinson's disease (PD). Very little is known about the cause for nocturia. The aim of this work was to evaluate lower urinary tract (LUT) symptoms in patients with PD reporting nocturia using standardized validated questionnaires and bladder diaries and to assess the impact of nocturia on quality of life and sleep.

Methods: Twenty-three consecutive patients with PD (17 males, 6 females; mean age: 68.5 years; range, 50-85) referred to a specialist uro-neurology clinic reporting nocturia according to the International Continence Society definition were included. Patients measured their daily fluid intake, urinary output per void, and recorded these with the timing of voids on a 3-day bladder diary. Standardized questionnaires were used to assess LUT symptoms (Urinary Symptom Profile, International Prostate Symptom Score, and Qualiveen Short Form) and sleep quality (Parkinson's Disease Sleep Scale).

Results: Mean duration of PD was 10.1 years, and mean severity on H & Y scale was 3.0 (range, 1.0-5.0). Median duration of LUT symptoms was 6.0 years. Mean night-time urinary frequency was 3.5 (range, 1.0-7.3), and mean nocturnal maximum voided volume was 242 mL. Mean Nocturnal Polyuria Index (NPi) was 0.4 (range, 0.13-0.75), and 13 patients (56.5%) had nocturnal polyuria (NPi > 0.33). Patients with nocturnal polyuria reported more-severe LUT symptoms that impacted quality of life and sleep.

Conclusions: In this preliminary study, nocturnal polyuria seems to be common in patients with PD reporting nocturia and appears to affect quality of life and sleep, though this was not statistically significant. The bladder diary is an essential tool in the assessment of nocturia in patients with PD.

Citing Articles

Pelvic autonomic dysfunction is common in patients with pure autonomic failure.

Vichayanrat E, Hentzen C, Simeoni S, Pakzad M, Iodice V, Panicker J Eur J Neurol. 2024; 31(12):e16486.

PMID: 39344662 PMC: 11555151. DOI: 10.1111/ene.16486.

Molecular Mechanism Operating in Animal Models of Neurogenic Detrusor Overactivity: A Systematic Review Focusing on Bladder Dysfunction of Neurogenic Origin.

Ferreira A, Nascimento D, Cruz C Int J Mol Sci. 2023; 24(4).

PMID: 36834694 PMC: 9959149. DOI: 10.3390/ijms24043273.

Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care.

Bluett B, Pantelyat A, Litvan I, Ali F, Apetauerova D, Bega D Front Neurol. 2021; 12:694872.

PMID: 34276544 PMC: 8284317. DOI: 10.3389/fneur.2021.694872.

Neurogenic Bladder: Epidemiology, Diagnosis, and Management.

Panicker J Semin Neurol. 2020; 40(5):569-579.

PMID: 33065745 PMC: 9715349. DOI: 10.1055/s-0040-1713876.

Executive Function Is Related to the Urinary Urgency in Non-demented Patients With Parkinson's Disease.

Tkaczynska Z, Becker S, Maetzler W, Timmers M, van Nueten L, Sulzer P Front Aging Neurosci. 2020; 12:55.

PMID: 32210789 PMC: 7069351. DOI: 10.3389/fnagi.2020.00055.

References

Winge K, Fowler C . Bladder dysfunction in Parkinsonism: mechanisms, prevalence, symptoms, and management. Mov Disord. 2006; 21(6):737-45. DOI: 10.1002/mds.20867. View

Weiss J . Nocturia: "do the math". J Urol. 2006; 175(3 Pt 2):S16-8. DOI: 10.1016/S0022-5347(05)00312-5. View

Plywaczewski R, Stoklosa A, Bednarek M, Czerniawska J, Bielen P, Gorecka D . [Nocturia in obstructive sleep apnoea (OSA)]. Pneumonol Alergol Pol. 2007; 75(2):140-6. View

Scarpa R . Lower urinary tract symptoms: what are the implications for the patients?. Eur Urol. 2002; 40 Suppl 4:12-20. DOI: 10.1159/000049890. View

Aziz N, Pijl H, Frolich M, Roelfsema F, Roos R . Diurnal secretion profiles of growth hormone, thyrotrophin and prolactin in Parkinson's disease. J Neuroendocrinol. 2011; 23(6):519-24. DOI: 10.1111/j.1365-2826.2011.02134.x. View

Weiss J, Wein A, Van Kerrebroeck P, Dmochowski R, Fitzgerald M, Tikkinen K . Nocturia: new directions. Neurourol Urodyn. 2011; 30(5):700-3. DOI: 10.1002/nau.21125. View

Xue P, Wang T, Zong H, Zhang Y . Urodynamic analysis and treatment of male Parkinson's disease patients with voiding dysfunction. Chin Med J (Engl). 2014; 127(5):878-81. View

Cornu J, Abrams P, Chapple C, Dmochowski R, Lemack G, Michel M . A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis. Eur Urol. 2012; 62(5):877-90. DOI: 10.1016/j.eururo.2012.07.004. View

Nakagawa H, Niu K, Hozawa A, Ikeda Y, Kaiho Y, Ohmori-Matsuda K . Impact of nocturia on bone fracture and mortality in older individuals: a Japanese longitudinal cohort study. J Urol. 2010; 184(4):1413-8. DOI: 10.1016/j.juro.2010.05.093. View

10.

Araki I, Kitahara M, Oida T, Kuno S . Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms. J Urol. 2000; 164(5):1640-3. View

11.

Reynard J . A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. Br J Urol. 1999; 82(6):932. View

12.

Mathias C, Fosbraey P, da Costa D, Thornley A, Bannister R . The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. Br Med J (Clin Res Ed). 1986; 293(6543):353-4. PMC: 1341045. DOI: 10.1136/bmj.293.6543.353. View

13.

Barry M, Fowler Jr F, OLeary M, Bruskewitz R, HOLTGREWE H, MEBUST W . The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992; 148(5):1549-57; discussion 1564. DOI: 10.1016/s0022-5347(17)36966-5. View

14.

van Kerrebroeck P, Weiss J . Standardization and terminology of nocturia. BJU Int. 2000; 84 Suppl 1:1-4. DOI: 10.1046/j.1464-410x.84.s1.7.x. View

15.

Van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S . The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002; 21(2):179-83. DOI: 10.1002/nau.10053. View

16.

Weiss J, Blaivas J, Bliwise D, Dmochowski R, DuBeau C, Lowe F . The evaluation and treatment of nocturia: a consensus statement. BJU Int. 2011; 108(1):6-21. DOI: 10.1111/j.1464-410X.2011.10175.x. View

17.

Sakakibara R, Matsuda S, Uchiyama T, Yoshiyama M, Yamanishi T, Hattori T . The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria. Clin Auton Res. 2003; 13(2):106-8. DOI: 10.1007/s10286-003-0052-3. View

18.

Chaudhuri K, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R . The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2002; 73(6):629-35. PMC: 1757333. DOI: 10.1136/jnnp.73.6.629. View

19.

Bonniaud V, Bryant D, Parratte B, Guyatt G . Development and validation of the short form of a urinary quality of life questionnaire: SF-Qualiveen. J Urol. 2008; 180(6):2592-8. DOI: 10.1016/j.juro.2008.08.016. View

20.

Saini J, Axelrod F, Maayan C, Stringer J, Smilen S . Urinary incontinence in familial dysautonomia. Int Urogynecol J Pelvic Floor Dysfunct. 2003; 14(3):209-13; discussion 213. DOI: 10.1007/s00192-002-1022-3. View